AB Sciex Taking over Management of Beckman Coulter's Capillary Electrophoresis Unit | GenomeWeb

NEW YORK (GenomeWeb News) – AB Sciex today announced that it is combining its Eksigent chromatography business with the capillary electrophoresis unit of its fellow Danaher stablemate Beckman Coulter.

The move, which the company said will include the transfer of personnel as well as technology, is designed to bolster AB Sciex's separations business and could aid in advancing analysis of target drugs, drug metabolites, organic acids, amino acids, low molecular weight amines, peptides, nucleic acids, and nucleosides.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.